Curis, Inc. - stock earnings
CRIS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 BeforeMarket | - / -1.9400000000 | - | - / 2.4 million | - |
CRIS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -11.8 million USD | 2.7 million USD |
| 2023Q3 | -12.2 million USD | 2.8 million USD |
| 2023Q2 | -12.0 million USD | 2.2 million USD |
| 2023Q1 | -11.5 million USD | 2.3 million USD |
| 2022Q4 | -12.4 million USD | 2.9 million USD |
| 2022Q3 | -14.0 million USD | 2.8 million USD |
| 2022Q2 | -16.8 million USD | 2.4 million USD |
| 2022Q1 | -17.1 million USD | 2.1 million USD |
| 2021Q4 | -13.6 million USD | 3.1 million USD |
| 2021Q3 | -11.1 million USD | 3.0 million USD |
| 2021Q2 | -10.8 million USD | 2.3 million USD |
| 2021Q1 | -9.9 million USD | 2.2 million USD |
| 2020Q4 | -7.5 million USD | 3.0 million USD |
| 2020Q3 | -6.0 million USD | 2.7 million USD |
| 2020Q2 | -6.7 million USD | 2.4 million USD |
| 2020Q1 | -9.7 million USD | 2.7 million USD |
| 2019Q4 | -8.6 million USD | 3.3 million USD |
| 2019Q3 | -6.4 million USD | 2.9 million USD |
| 2019Q2 | -7.2 million USD | 2.1 million USD |
| 2019Q1 | -9.9 million USD | 1.8 million USD |
| 2018Q4 | -5.9 million USD | 2.8 million USD |
| 2018Q3 | -7.2 million USD | 2.8 million USD |
| 2018Q2 | -8.7 million USD | 2.4 million USD |
| 2018Q1 | -10.7 million USD | 2.5 million USD |
| 2017Q4 | -8.0 million USD | 3.3 million USD |
| 2017Q3 | -15.5 million USD | 2.4 million USD |
| 2017Q2 | -14.1 million USD | 2.1 million USD |
| 2017Q1 | -15.7 million USD | 2.1 million USD |
| 2016Q4 | -11.3 million USD | 2.4 million USD |
| 2016Q3 | -28.3 million USD | 1.8 million USD |
| 2016Q2 | -11.3 million USD | 1.7 million USD |
| 2016Q1 | -9.4 million USD | 1.7 million USD |
| 2015Q4 | -13.5 million USD | 2.1 million USD |
| 2015Q3 | -5.5 million USD | 2.0 million USD |
| 2015Q2 | -8.1 million USD | 2.1 million USD |
| 2015Q1 | -31.8 million USD | 1.7 million USD |
| 2014Q4 | -5.7 million USD | 2.0 million USD |
| 2014Q3 | -5.6 million USD | 1.8 million USD |
| 2014Q2 | -1.9 million USD | 4.8 million USD |
| 2014Q1 | -5.6 million USD | 1.3 million USD |
| 2013Q4 | -4.2 million USD | 1.5 million USD |
| 2013Q3 | -1.9 million USD | 7.2 million USD |
| 2013Q2 | -1.3 million USD | 5.4 million USD |
| 2013Q1 | -5.0 million USD | 871435 USD |
| 2012Q4 | -12.4 million USD | 1.7 million USD |
| 2012Q3 | -3.4 million USD | 577759 USD |
| 2012Q2 | -2.9 million USD | 4.4 million USD |
| 2012Q1 | 2.2 million USD | 10.4 million USD |
| 2011Q4 | 6.1 million USD | 14.1 million USD |
| 2011Q3 | -4.2 million USD | 147122 USD |
| 2011Q2 | -4.9 million USD | 392867 USD |
| 2011Q1 | -6.8 million USD | 133538 USD |
| 2010Q4 | -5.6 million USD | 100287 USD |
| 2010Q3 | -1.5 million USD | 3.2 million USD |
| 2010Q2 | -2.1 million USD | 98634 USD |
| 2010Q1 | 4.8 million USD | 12.6 million USD |
| 2009Q4 | -2.7 million USD | 1.7 million USD |
| 2009Q3 | -4.1 million USD | 765313 USD |
| 2009Q2 | -4.2 million USD | 63263 USD |
| 2009Q1 | 1.1 million USD | 6.0 million USD |
| 2008Q4 | -2.2 million USD | 3.1 million USD |
| 2008Q3 | -4.6 million USD | 86721 USD |
| 2008Q2 | -2.0 million USD | 3.1 million USD |
| 2008Q1 | -3.4 million USD | 2.1 million USD |
| 2007Q4 | 4.3 million USD | 11.5 million USD |
| 2007Q3 | -3.7 million USD | 1.3 million USD |
| 2007Q2 | -4.0 million USD | 1.2 million USD |
| 2007Q1 | -3.5 million USD | 2.4 million USD |
| 2006Q4 | 680494 USD | 4.3 million USD |
| 2006Q3 | -1.5 million USD | 4.6 million USD |
| 2006Q2 | -3.9 million USD | 3.1 million USD |
| 2006Q1 | -4.0 million USD | 2.9 million USD |
| 2005Q4 | -1.4 million USD | 3.2 million USD |
| 2005Q3 | -3.6 million USD | 1.8 million USD |
| 2005Q2 | -4.7 million USD | 1.5 million USD |
| 2005Q1 | -5.1 million USD | 2.8 million USD |
| 2004Q4 | -1.7 million USD | 1.5 million USD |
| 2004Q3 | -3.9 million USD | 1.5 million USD |
| 2004Q2 | -4.3 million USD | 1.1 million USD |
| 2004Q1 | -4.0 million USD | 855805 USD |
| 2003Q4 | -6.9 million USD | 755095 USD |
| 2003Q3 | 4.5 million USD | 9.3 million USD |
| 2003Q2 | -4.9 million USD | 548942 USD |
| 2003Q1 | -4.3 million USD | 435358 USD |
| 2002Q4 | 12.3 million USD | 17.8 million USD |
| 2002Q3 | -5.8 million USD | 222351 USD |
| 2002Q2 | -71.0 million USD | 189603 USD |
| 2002Q1 | -17.8 million USD | 158632 USD |
| 2001Q4 | -16.3 million USD | 346785 USD |
| 2001Q3 | -28.5 million USD | 287915 USD |
| 2001Q2 | -19.3 million USD | 202638 USD |
| 2001Q1 | -17.8 million USD | 2.7 million USD |
| 2000Q4 | -19.1 million USD | 253265 USD |
| 2000Q3 | -322.9 million USD | 65955 USD |
| 2000Q2 | ? USD | 8000 USD |
| 2000Q1 | ? USD | 670000 USD |
CRIS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -47.4 million USD | 10.0 million USD |
| 2022 | -60.3 million USD | 10.2 million USD |
| 2021 | -50.6 million USD | 10.6 million USD |
| 2020 | -34.9 million USD | 10.8 million USD |
| 2019 | -36.8 million USD | 10.0 million USD |
| 2018 | -32.6 million USD | 10.4 million USD |
| 2017 | -53.3 million USD | 9.9 million USD |
| 2016 | -60.4 million USD | 7.5 million USD |
| 2015 | -59.0 million USD | 7.9 million USD |
| 2014 | -18.7 million USD | 9.8 million USD |
| 2013 | -12.3 million USD | 15.0 million USD |
| 2012 | -16.4 million USD | 17.0 million USD |
| 2011 | -9.9 million USD | 14.8 million USD |
| 2010 | -4.4 million USD | 16.0 million USD |
| 2009 | -9.8 million USD | 8.6 million USD |
| 2008 | -12.1 million USD | 8.4 million USD |
| 2007 | -7.0 million USD | 16.4 million USD |
| 2006 | -8.8 million USD | 14.9 million USD |
| 2005 | -14.9 million USD | 6.0 million USD |
| 2004 | -13.9 million USD | 5.0 million USD |
| 2003 | -11.6 million USD | 11.0 million USD |
| 2002 | -82.3 million USD | 18.4 million USD |
| 2001 | -81.9 million USD | 1.1 million USD |
| 2000 | -350.4 million USD | 997078 USD |
| 1999 | -12.1 million USD | 3.2 million USD |
CRIS
Price: $16.10
52 week price:
Earnings Per Share: -8.96 USD
P/E Ratio: -0.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 479800
Ebitda: -14.2 millionMarket Capitalization: 96.4 million